about
Regulated Gene Therapy.Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease.A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses.Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat.Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats.Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainGDNF-mediated rescue of the nigrostriatal system depends on the degree of degenerationOptimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vectorGenetically engineered animal models of Parkinson's disease: From worm to rodentImpact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
P50
Q35853985-35E25853-CA92-4B76-B08B-332BAD6CB20FQ36198357-E61A40A9-A520-4A7E-9184-817FF07CAB9CQ36744851-F07B9D5F-E761-49D5-AA07-7B5E389B6A7DQ40044736-77D99B70-3578-46D0-9F75-BC07D36A77BFQ43619672-52494B0D-84D0-4168-98E4-44B1FAD4D4E3Q48464731-9B898115-A439-420C-820E-C77E1D174E4DQ55546568-F029D9E9-0866-4EAB-8E50-08EB4D05259AQ57493992-439E2485-0D1B-47FF-97CF-6529421E76B9Q64791479-D0217400-8CE1-468F-A13A-35D7CAC7DDACQ89527712-673B95F7-7544-4FE4-AD76-75564650B6B6Q90534676-4AC0EBBB-5564-4320-9D6C-16028FF06855Q96429672-E1F247D5-D3FC-460C-8C4D-C04709BD6A2E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ludivine S Breger
@ast
Ludivine S Breger
@en
Ludivine S Breger
@es
Ludivine S Breger
@nl
type
label
Ludivine S Breger
@ast
Ludivine S Breger
@en
Ludivine S Breger
@es
Ludivine S Breger
@nl
prefLabel
Ludivine S Breger
@ast
Ludivine S Breger
@en
Ludivine S Breger
@es
Ludivine S Breger
@nl
P106
P31
P496
0000-0003-0915-8755